statistiche ricercatore

Continente	#
NA - Nord America	487
EU - Europa	335
AS - Asia	274
SA - Sud America	47
Continente sconosciuto - Info sul continente non disponibili	25
AF - Africa	4
Totale	1.172

Nazione	#
US - Stati Uniti d'America	468
SG - Singapore	116
IE - Irlanda	69
UA - Ucraina	61
IT - Italia	45
DE - Germania	44
HK - Hong Kong	37
RU - Federazione Russa	37
VN - Vietnam	35
CN - Cina	34
BR - Brasile	31
FI - Finlandia	26
FR - Francia	26
KR - Corea	17
GB - Regno Unito	9
BD - Bangladesh	6
EC - Ecuador	5
IQ - Iraq	5
MX - Messico	5
SE - Svezia	5
CA - Canada	4
CO - Colombia	4
GT - Guatemala	4
ID - Indonesia	4
IN - India	4
AR - Argentina	3
CZ - Repubblica Ceca	3
PK - Pakistan	3
AE - Emirati Arabi Uniti	2
CH - Svizzera	2
JM - Giamaica	2
JP - Giappone	2
MY - Malesia	2
PH - Filippine	2
RO - Romania	2
TR - Turchia	2
TT - Trinidad e Tobago	2
AT - Austria	1
BE - Belgio	1
BO - Bolivia	1
CL - Cile	1
CR - Costa Rica	1
EE - Estonia	1
ES - Italia	1
ET - Etiopia	1
EU - Europa	1
JO - Giordania	1
KE - Kenya	1
KZ - Kazakistan	1
LT - Lituania	1
MA - Marocco	1
NL - Olanda	1
OM - Oman	1
PR - Porto Rico	1
PY - Paraguay	1
VE - Venezuela	1
XK - ???statistics.table.value.countryCode.XK???	1
ZA - Sudafrica	1
Totale	1.149

Nome	#
Well differentiated thoracic neuroendocrine tumors: clinical management and therapy	128
Analoghi della somatostatina nei tumori neuroendocrini gastro-entero-pancreatici e toracici	113
Surgical treatment of well differentiated neuroendocrine tumours of the lung	112
18F-deoxy-D-glucose positron emission tomography (FDG_PET) increases the detection rate of recurrent or residual medullary thyroid cancer	111
Evaluation of accuracy of circulating CgA and NSE in the pre- and post-operative phase in bronchial carcinoids	102
Shortened interval of octreotide LAR administration is effective in patients with well differentiated neuroendocrine carcinomas in progression on standard doses.	96
The biological characterization of neuroendocrine tumors: the role of neuroendocrine markers.	93
Comorbilità di ansia e depressione nei pazienti con tumori carcinoidi - Comorbility between anxiety and depression in patients with carcinoid tumors -	92
Shortened interval of long-acting octreotide administration is effective in patients with well-differentiated neuroendocrine carcinomas in progression on standard doses.	88
LA TERAPIA DEI PROLATTINOMI IN TEMPO DI SPENDING REVIEW. BROMOCRIPTINA vs CABERGOLINA: ANALISI COSTO-EFFICACIA	86
macro-prolactinomas:which the therapeutic space of dopamine-agonists?	80
CD 44 expression as a major prognostic factor in lung neuroendocrine tumors	71
Totale	1.172

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	58	0	0	0	0	0	0	0	32	1	1	12	12
2022/2023	198	12	20	7	9	21	15	0	16	82	0	10	6
2023/2024	65	6	3	5	2	1	1	16	0	10	0	8	13
2024/2025	163	11	14	12	5	18	6	0	10	31	7	32	17
2025/2026	352	29	27	20	48	53	24	41	11	65	25	7	2
2026/2027	101	7	6	26	58	4	0	0	0	0	0	0	0
Totale													1.172

IRIS - Res&Arch Institutional Research Information System - Research & Archive